Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/26/2026

1. MU
2. QCOM
3. SPY
4. JPM
5. ICLR
6. USO
7. LAES
8. FUL

Go back to Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial
(NASDAQ: GCTK) Delayed: 0.33 -0.02 (5.71%)
Previous Close $0.35    52 Week High $ 
Open $0.35    52 Week Low $ 
Day High $0.35    P/E N/A 
Day Low $0.33    EPS $ 
Volume 232,040